24/7 Market News Snapshot 17 March, 2025 – Quantum Biopharma Ltd. Class B Subordinate Voting Shares (NASDAQ:QNTM)

March 17, 2025

DENVER, Colo., 17 March, 2025 (247marketnews.com) – (NASDAQ:QNTM) are discussed in this article.
Quantum Biopharma Ltd. has recently captured attention within the financial markets, reflecting a significant upswing in investor interest. The Class B Subordinate Voting Shares of Quantum Biopharma opened at $5.57 and surged to a notable high of $7.168, marking an incredible increase of over 46.58% in a single trading session. The stock closed the previous day at $4.890, showcasing a vigorous bullish trend with a current trading volume reaching 8.15 million shares. Market analysts are closely monitoring this momentum, eager to see if it sustains as the company forges ahead in the biopharmaceutical arena.

In light of this market enthusiasm, Quantum Biopharma management has issued a statement affirming that there are no material changes to its operational activities at this time. Dedicated to advancing treatment in neurodegenerative disorders and metabolic conditions, Quantum Biopharma is particularly focused on its leading candidate, Lucid-MS. This novel compound aims to prevent and potentially reverse myelin degradation in multiple sclerosis, an area in critical need of effective therapies. Preclinical studies have reportedly shown promising results, establishing Lucid-MS as a key player in the company’s product pipeline.

Furthermore, Quantum has secured a strategic partnership with Celly Nutrition Corp. for the innovative product unbuzzd™, retaining a 25.71% ownership stake in the endeavor. The collaboration is designed to generate substantial revenue through royalty payments, reinforcing Quantum’s commitment to growth without compromising its control over alternative pharmaceutical formulations.

Additionally, through its subsidiary FSD Strategic Investments Inc., Quantum is enhancing its strategic growth initiatives by investing in secured loans backed by real estate, thereby diversifying its portfolio. As Quantum Biopharma continues to advance its mission of providing transformative health solutions, the company positions itself as a pivotal force in addressing contemporary health challenges.

Related news for (QNTM)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.